Connect with us

Business

Psychedelics for Athletes Goes Mainstream as ESPN and CNN Plan Documentaries on Shrooms

Published

on

ESPN and CNN have shows coming out on the mainstream transition for psychdelics

ESPN and CNN are both pushing the envelope on psychedelics, with CNN having a new show, called “The Whole Story”, with Anderson Cooper, and ESPN focusing on athletes that are finding hope with the use of psychedelics. While NY Jets quarterback Aaron Rodgers has openly discussed his psychedelic use, most athletes are just trying them now for medicinal purposes.

Let’s cut the to the ESPN storyline as the show opens!

A boxer was overwhelmed by a sense of brokenness. Each morning greeted him with relentless pain. Some days, it manifested as excruciating headaches, while on other occasions, his back, fists, ribs, or nose would ache. To add to his burden, he battled mood swings along with depression and anxiety.

Mike Lee, however, held no regrets about his career. He had attained the pinnacle of success as one of the world’s finest professional fighters in his weight class. Boasting an impressive record of 21-1, he had graced the legendary Madison Square Garden and captivated millions of viewers on television.Psychedelics On ESPN: Documentary Looks At Psychedelic Treatments For Athletes

But, over two years had passed since he last stepped into the boxing ring, and each day served as a poignant reminder of his sacrifices. At one juncture, Lee relied on eight prescription medications to alleviate his struggles.

In his darkest hour, amidst a harrowing battle with painkiller addiction, he admitted contemplating a dangerous act: hurtling his car into the median of a Chicago freeway at 140 mph. Desperate to break free from the torment that trapped him, he was prepared to undertake any measure possible.

The persistent pain endured as the impulsive thought waned, leaving him adrift in a sea of uncertainty. “When you find yourself trapped in a corner, consumed by pain, you become willing to do anything to break free,” expressed Lee.

In his present state, he found himself in a lush jungle, nestled at the end of a rugged path that wound halfway up a mountain. Holding onto a glimmer of hope, he believed that psychedelic mushrooms had the potential to transform his life.

Psychedelic Mushrooms: An Answered Prayer

In March 2022, Lee found himself among a select group, comprising retired athletes and others, who embarked on a journey to Jamaica. They were drawn together by a shared purpose, seeking solace from the burdens of depression, anxiety, and persistent chronic pain that had plagued them for years. Their destination was the Good Hope Estate, a former sugar plantation transformed into an exclusive resort, where they aspired to find respite.

Awaiting them at this retreat, organized by a Canadian company called Wake Network, were two transformative experiences: two psychedelic mushroom ceremonies and two therapy sessions. The participants felt a mixture of nerves and hope, uncertain yet optimistic about the potential outcomes that awaited them on this remarkable healing journey.

In the company of Lee, there was a professional football player contemplating retirement and a former hockey star haunted by multiple concussions. Hailing from various corners of North America and representing diverse backgrounds and sports, they shared a common thread: vulnerability and a profound disillusionment with prescription medications.

Uncertain of what lay ahead, they embarked on this collective journey, united by a desire for healing. They grappled with unanswered questions: Would the treatment prove effective? Would they discover a solution that could mend their struggles? Or would they encounter further disappointment, exacerbating their existing uncertainties?

Lee learned about the retreat through a childhood friend currently serving as a Wake doctor. Additional participants were brought in by Riley Cote, a former enforcer for the Philadelphia Flyers, who has transitioned into a psychedelics advocate and now advises Wake, holding an ownership interest.

Riley Cote, The Ex-Enforcer

Riley Cote, a former professional hockey player, was once similar to Lee, finding joy in physically engaging with others by delivering forceful punches to the face. The impact of his knuckles meeting flesh and bone at high speed, causing his opponents’ heads to snap back, provided Cote with a sense of vitality.

However, Cote’s path has now diverged. He has transitioned from being a pro athlete to becoming a yoga instructor and a passionate advocate for psychedelics. Additionally, Cote is interested in Wake Network, a Canadian company focused on psilocybin, the compound found in magic mushrooms.

This transition has attracted attention, with ESPN reporting on whispers of an underground network of athletes, particularly former ones, using psilocybin to address issues such as traumatic brain injuries, anxiety, and depression.

Like Cote, numerous individuals perceive psychedelics as a transformative remedy—an elusive solution that breaks free from the relentless cycle of pharmaceutical painkillers and substance dependency. These individuals congregate in intimate clusters, privately consuming mushrooms or venturing to destinations like Jamaica, where psychedelic mushrooms remain unrestricted, searching for profound experiences.

Psychedelic Mushrooms Gain More Acceptance in the United States

There is a growing interest in the United States regarding the use of psychedelic mushrooms. Several cities have decriminalized the possession of psilocybin, and ballot measures in Oregon and Colorado have legalized magic mushrooms for supervised use. Some researchers anticipate that the FDA may approve psychedelic treatments within the next five years.

However, these researchers caution that psychedelics’ excitement surpasses scientific evidence and that the treatment carries significant risks for certain patients. They worry that without systematic and ethical research, the widespread use of psilocybin could lead to a public backlash similar to what occurred in the 1960s, potentially relegating a promising treatment to banned substances.

They are urging corporate entities like Wake, which are already positioning themselves to capitalize on the potential legalization of psychedelics, to proceed cautiously. They emphasize the importance of conducting research properly and allowing scientific knowledge to catch up.

Matthew Johnson, a psychiatry professor and psychedelics researcher at Johns Hopkins University, stated, “If mushrooms are not used safely, people are going to get hurt.”

However, many individuals, including former professional athletes dealing with physical and cognitive injuries, are unwilling to wait for the slow progress of clinical research. They need assistance immediately, as the painkillers, antidepressants, and numerous other medications they have been prescribed over the years have not provided relief. In their view, the positive experiences shared by fellow athletes who have benefited from psychedelics outweigh any scientific uncertainties.

According to Cote, all the former athletes who participate in these retreats face challenges and need assistance. Many feel like they have exhausted all other options and tried various approaches. They question why they should wait when numerous studies and personal accounts highlight positive outcomes.

Cote drew a parallel with cannabis, pointing out that it took numerous stories and experiences before establishing a medical program. He expressed frustration that progress has been hindered for such a long time.

Conclusion

The journey of former athletes like Mike Lee and the growing interest in psychedelic mushrooms reveal the struggles faced by individuals grappling with chronic pain, depression, and anxiety. While the potential benefits of psychedelics offer hope, researchers emphasize the need for proper research and caution to ensure safety.

The urgency those seeking relief feel highlights the complex balance between scientific evidence and personal experiences. As society navigates the path toward acceptance, it becomes crucial to prioritize scientific exploration while addressing the immediate needs of individuals yearning for transformative solutions.

Source: https://cannabis.net/blog/news/psychedelics-for-athletes-goes-mainstream-as-espn-and-cnn-plan-documentaries-on-shrooms

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News